1. MAPK/ERK Pathway
    Stem Cell/Wnt
  2. ERK

XMD17-109 

Cat. No.: HY-15665
Handling Instructions

XMD17-109 is a novel, specific ERK-5 inhibitor, which inhibits the ERK5-mediated AP1 transcriptional activity at 30 μM, and has an EC50 of 4.2 μM.

For research use only. We do not sell to patients.
XMD17-109 Chemical Structure

XMD17-109 Chemical Structure

CAS No. : 1435488-37-1

Size Price Stock Quantity
Free Sample (0.5-1 mg)   Apply now  
10 mM * 1 mL in DMSO $197 In-stock
5 mg $140 In-stock
10 mg $220 In-stock
50 mg $620 In-stock
100 mg   Get quote  
200 mg   Get quote  

* Please select Quantity before adding items.

    XMD17-109 purchased from MCE. Usage Cited in: Oncotarget. 2016 Jun 7;7(23):34322-40.

    HCT116 parental cells are treated for up to 48 h with increasing doses of 5-FU in combination with 4 μM XMD8-92 or 2 μM XMD17-109, two highly-selective ERK5 pharmacological inhibitors.
    • Biological Activity

    • Protocol

    • Technical Information

    • References

    Description

    XMD17-109 is a novel, specific ERK-5 inhibitor, which inhibits the ERK5-mediated AP1 transcriptional activity at 30 μM, and has an EC50 of 4.2 μM.

    In Vitro

    XMD17-109 demonstrats low nanomolar cellular activity judged by the significant dose-dependent reduction of mobility shifted phosphorylated ERK5 bands from sorbitol stimulated cells. XMD17-109 completely inhibits the ERK5-mediated AP1 transcriptional activity at 30 μM and has an EC50 of 4.2 μM[1].

    References
    Preparing Stock Solutions
    Concentration Volume (DMSO) Mass 1 mg 5 mg 10 mg
    1 mM 1.5654 mL 7.8272 mL 15.6544 mL
    5 mM 0.3131 mL 1.5654 mL 3.1309 mL
    10 mM 0.1565 mL 0.7827 mL 1.5654 mL
    Cell Assay
    [1]

    HeLa cells are maintained in DMEM supplemented with 10% FBS, 2 mM l-glutamine, 50 U/mL penicillin G, and 50 μg/mL streptomycin. Before use HeLa cells are serum starved for 16 h in DMEM supplemented with 2 mM l-glutamine, 50 U/mL penicillin G, and 50 μg/mL streptomycin. HeLa cells are then incubated with ERK5-IN-1 at the indicated concentrations for 1 h prior to stimulation with 0.5mol/Lsorbitol for 30 min. Cells are lysed in Triton lysis buffer (50 mM Tris-HCl, pH 7.5, 1 mM EGTA, 1 mM EDTA, 1 mM sodium orthovanadate, 50 mM sodium fluoride, 1 mM sodium pyrophosphate, 0.27mol/Lsucrose, 1 μM microcystin-LR, 1% (v/v) Triton X-100, 0.1% (v/v) 2-mercaptoethanol) and 20 μg of protein loaded per well. Samples are run on 8% polyacrylamide gels using standard methods. Proteins are transferred onto nitrocellulose membranes and specific proteins detected by immunoblotting. MCE has not independently confirmed the accuracy of these methods. They are for reference only.

    References
    Molecular Weight

    638.8

    Formula

    C₃₆H₄₆N₈O₃

    CAS No.

    1435488-37-1

    Storage

    Please store the product under the recommended conditions in the Certificate of Analysis.

    Shipping

    Room temperature in continental US; may vary elsewhere

    Solvent & Solubility

    10 mM in DMSO

    XMD17-109 is dissolved in 30% (2-hydroxypropyl)-β-cyclodextrin[2].

    * "<1 mg/mL" means slightly soluble or insoluble. "≥" means soluble, but saturation unknown.

    References

    Inquiry Online

    Your information is safe with us. * Required Fields.

    Product name

     

    Salutation

    Applicant name *

     

    Email address *

    Phone number

     

    Organization name *

    Country *

     

    Requested quantity *

    Remarks

    Bulk Inquiry

    Inquiry Information

    Product Name:
    XMD17-109
    Cat. No.:
    HY-15665
    Quantity: